The expansion of these clones after release from competition by the deletion of IDEs explains previous data that had shown that CD8+ T cells specific for non-IDEs can substitute for IDE-specific cells in protection against infection with an IDE deletion mutant. The gene discussed is CD8A; the disease is infection.